Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Research and development

Litigation settlement gain

Restructuring and other charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Align Technology

Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Align Technology reports Q4 growth, eyes tech advancements for 2023

Align Technology's Q4 performance showed revenue growth in Systems and Services but challenges in Clear Aligner volumes, particularly in China.
The company is focusing on technology advancements, digital subscriptions, and margin improvement for 2023.
Investments in R&D for digital orthodontics and subscription programs present opportunities for future growth.
Despite challenges in China, Align remains optimistic about stability and growth in other regions.

Align Technology beats Q1 revenue expectations, eyes Q2 growth

Align Technology's Q1 performance exceeded expectations with revenue growth.
Stable Clear Aligner business and focus on teen market are strengths.
Challenges include increased expenses and uncertainty in margins.
Opportunities lie in expected volume and ASP increases in Q2.

Align Technology surpasses Q2 expectations, eyes international growth opportunities

Align Technology delivered strong Q2 results, driven by revenue growth in Clear Aligner and Systems and Services segments, with a focus on innovation and strategic initiatives.
The company's performance in international markets, particularly EMEA and APAC, showcased significant growth in teen cases and adoption of the DSP program.
While facing challenges in the teen market and competitive landscape, Align Technology remains optimistic about its long-term growth prospects and market positioning.
Opportunities for Align include continued innovation, market expansion, and investor engagement through strategic initiatives and product differentiation.

Align Technology reports Q3 revenue growth amidst macro challenges

Align Technology navigated challenges in Q3 with revenue growth driven by clear aligner shipments to younger patients and increased services revenue.
Despite lower Q3 demand, the company remains optimistic for 2024 revenue growth through new technologies and digital orthodontics adoption.
Strategic investments in R&D, cost management, and consumer advertising position Align Technology for future growth and margin improvement.

Align Technology surpasses Q4 expectations, eyes innovation for growth

Align Technology delivered strong financial performance in Q4 2023, with robust revenue growth and effective cost management.
The company's focus on innovation, strategic partnerships, and market expansion positions it well for future growth.
While facing challenges such as regulatory approvals and cash flow fluctuations, Align Technology has opportunities in market expansion and cost-saving initiatives.
Overall, Align Technology's performance, strengths, and strategic outlook indicate a positive trajectory for sustainable growth and profitability.

Align Technology posts solid Q1 earnings, eyes growth opportunities

Align Technology's Q1 performance reflects revenue growth and strategic investments in innovation and market expansion.
While facing challenges in operating expenses and margin decline, the company's strengths lie in product innovation and brand visibility.
Opportunities in new market expansion, targeting younger patients, and operational investments set the stage for future growth and profitability.

Align Technology posts solid Q2 results, eyes market expansion

Align Technology delivered strong financial performance in Q2, driven by revenue growth, margin expansion, and increasing adoption of its innovative solutions.
The company's focus on product innovation, digital tools, and marketing initiatives has bolstered its market position and customer engagement.
While facing challenges in a competitive landscape and regulatory processes, Align Technology remains well-positioned to capitalize on opportunities in the orthodontic market.
Strategic initiatives to drive growth, enhance operational efficiency, and expand market reach are key priorities for sustaining momentum and profitability.

Align Technology reports mixed Q3 results, eyes international growth

Align Technology's Q3 '24 showcased mixed results but highlighted growth opportunities in international markets and new product innovations.
Despite challenges in the U.S. market, the company's strategic focus on operational efficiency and digital innovation positions it for future success.
Investments in expansion and supporting doctor customers signal a commitment to driving growth and profitability in the long term.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

ResMed

Vertex Pharmaceuticals

Well-known guidance from Warren Buffett can help us identify opportunities in an expensive market.

3 Top Value Stocks in Healthcare to Buy Right Now

Align Technology is near a possible buy zone ahead of its next quarterly earnings report, expected on or around Apr. 28. The post Stocks To Watch Ahead Of Earnings: Align Technology appeared first on Investor's Business Daily.

Stocks To Watch Ahead Of Earnings: Align Technology

Align Technology (ALGN) closed at $603.72 in the latest trading session, marking a -0.43% move from the prior day.

Align Technology (ALGN) Stock Moves -0.43%: What You Should Know

Does Align Technology (ALGN) have what it takes to be a top stock pick for momentum investors? Let's find out.

What Makes Align Technology (ALGN) a Strong Momentum Stock: Buy Now?

As of late, it has definitely been a great time to be an investor in Align Technology (ALGN).

Align Technology's (ALGN) Shares March Higher, Can It Continue?

ICON

PRA Health Sciences

STERIS

Teladoc

Thermo Fisher Scientific

DENTSPLY SIRONA

While smaller tuck-in acquisitions dominated the M&A space throughout 2020, 2021 is seeing a number of colossal deals.

MedTech M&A Scaling New Heights in 2021 on Rising Investor Wealth

Align Technology (ALGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Align Technology (ALGN) Moves to Buy: Rationale Behind the Upgrade

XRAY vs. ALGN: Which Stock Is the Better Value Option?

Align Technology is forming a base and near a possible buy zone ahead of its earnings report expected around Apr. 28 . The post Earnings Season Preview: Align Technology Near Buy Zone With EPS Due appeared first on Investor's Business Daily.

Earnings Season Preview: Align Technology Near Buy Zone With EPS Due

Investors continue to be optimistic about Align Technology (ALGN) on solid customer adoption of Invisalign and iTero products.

Reasons to Hold on to Align Technology (ALGN) Stock for Now

Timely and convenient access to vaccinations is critical, now and in the future Timely and convenient access to vaccinations is critical, now and in the future

Align Technology Supports Efforts to Expand Access to Vaccinations by US Dentists

Molina Healthcare

STAAR Surgical

You probably haven't heard of these companies, but they're winners.

3 Outside-the-Box Healthcare Stocks That Could Set You Up for Life

TEMPE, Ariz., April 01, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report first quarter 2021 financial results on Wednesday, April 28, 2021, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Company's website at http://investor.aligntech.com.

Align Technology to Announce First Quarter 2021 Results on April 28, 2021

U.S. Ski & Snowboard Athletes to Join the Invisalign Smile Squad U.S. Ski & Snowboard Athletes to Join the Invisalign Smile Squad

Align Technology's Invisalign Brand is the Official Smile Partner of U.S. Ski & Snowboard

Capital One

Diamondback Energy

Landbridge Co LLC

Mosaic

We have narrowed down our search to five large-cap stocks that have skyrocketed more than 150% in the past year. These are: LB, MOS, COF, ALGN and FANG.

5 Top-Ranked Winners of Wall Street Since the Pandemic Trough

Etsy

1st Constitution Bancorp

PotlatchDeltic

Williams-Sonoma

The Driehaus strategy can be used to choose the best momentum stocks using the "buy high and sell higher" theory.

5 Top-Ranked Momentum Stocks Driven by Driehaus Strategy

Tapestry

After touching a low of 2,191 on Mar 23, 2020, the S&P 500 staged a strong comeback and is on track to hit a new milestone of 4,000.

5 S&P 500 Stocks That Zoomed 200% Plus From Pandemic Lows

A Company in a Hot Space and a Medical Device Company with "A" Rated Momentum.

Top Stock Picks for Week of March 22, 2021

EOG Resources

Nucor

Pioneer Natural Resources

We have narrowed down our search to the five large-cap S&P 500 stocks that have strong growth potential in 2021. These are: PXD, LB, NUE, ALGN and EOG.

U.S. GDP and Corporate Profits Likely to Soar in 2021: 5 Picks

Amkor Technology

Knowles

Here are three top-ranked Zacks stocks from the broader technology world that investors might want to buy amid inflation worries and market volatility.

3 Top-Ranked Tech Stocks to Buy Now Despite Volatility

Alibaba

Goldman Sachs

Home Depot

Humana

Investors often look to top fund managers to glean information on the best strategies and generate new investment ideas.

The Undervalued Holdings of the Decade's Top-Performing Gurus

Align Technology provides a luxury product that consumers are willing to pay up for.

This Company Thrived During the Pandemic, and the Reopening Could Push It Even Higher

Datadog

Stocks in the Nasdaq saw some volatility as the new week began.

Why These 2 High-Growth Favorites Lifted the Nasdaq Monday

Continued Strong Growth and Increasing Momentum for Invisalign Clear Aligners and iTero Systems and Services Across Products and Customer Channels Worldwide, Reflects the Strength of Align's Doctor-Directed Model and the Align Digital Platform Continued Strong Growth and Increasing Momentum for Invisalign Clear Aligners and iTero Systems and Services Across Products and Customer Channels Worldwide, Reflects the Strength of Align's Doctor-Directed Model and the Align Digital Platform

Arbitrator Requires SDC Financial, LLC to Pay Align an Additional $45.5 Million for a Total Award of $99.7 Million

Amazon

CrowdStrike

dMY Technology Group, Inc. III

Moderna

NVIDIA

QuantumScape

Snowflake

Regardless what an investor believes Bitcoin is worth, the technology behind it is impressive. But these eight stocks to buy offer significant innovation, too.

News for Align Technology Stock (ALGN)